Athanor Capital, LP Rhythm Pharmaceuticals, Inc. Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$20.25 - $39.49 $357,027 - $696,248	-17,631 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $110,316 - $169,930	5,211 Added 41.96%	17,631 $524,000
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $252,532 - $426,366	-13,929 Reduced 52.86%	12,420 $269,000
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $379,689 - $667,947	26,349 New	26,349 $588,000
Q1 2020 May 14, 2020	SELL	$13.16 - $22.9 $327,302 - $569,545	-24,871 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $485,730 - $634,210	24,871 New	24,871 $571,000

193

67.1M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.3B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.